Attached files
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002
In
connection with the annual report of Pharma-Bio Serv, Inc. (the
“Company”) on Form 10-K for the fiscal year ended
October 31, 2018 as filed with the Securities and Exchange
Commission on the date hereof (the “report”), the
undersigned, Victor Sanchez, Chief Executive Officer of the
Company, and Pedro J. Lasanta, Chief Financial Officer of the
Company, each certify, pursuant to 18 U.S.C. § 1350, as
adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002,
that to our knowledge:
|
1.
|
The
report fully complies with the requirements of Section 13(a) or
Section 15(d) of the Securities Exchange Act of 1934, as amended;
and
|
|
2.
|
The
information contained in the report fairly presents, in all
material respects, the financial condition and results of
operations of the Company.
|
Dated:
January 29, 2019
|
/s/
Victor Sanchez
|
|
/s/
Pedro J. Lasanta
|
|
Victor
Sanchez
|
|
Pedro
J. Lasanta
|
|
Chief
Executive Officer
|
|
Chief
Financial Officer
|
|
(principal
executive officer)
|
|
(principal
financial and accounting officer)
|
|
|
|
|
This certification accompanies the Form 10-K to which it relates,
is not deemed filed with the Securities and Exchange Commission and
is not to be incorporated by reference to any filing of Pharma-Bio
Serv, Inc. under the Securities Act of 1933, as amended, or the
Securities Exchange Act of 1934, as amended (whether made before or
after the date of the Form 10-K), irrespective of any general
incorporation language contained in such filing.